Predicting vertebral fractures: Small vertebral deformities increase the risk of subsequent vertebral fracture at one year - Early and effective fracture risk reduction with risedronate

被引：0
|
作者：
Felsenberg, D.
Recknor, C.
Zhou, X.
Grauer, A.
机构：
[1] Humboldt Univ, Muscle & Bone Res Ctr, Berlin, Germany
[2] United Osteoporosis Ctr, Gainesville, FL USA
[3] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [21] Risedronate reduces the risk of first vertebral fracture in osteoporotic women
    Heaney, RP
    Zizic, TM
    Fogelman, I
    Olszynski, WP
    Geusens, P
    Kasibhatla, C
    Alsayed, N
    Isaia, G
    Davie, MW
    Chesnut, CH
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 501 - 505
  • [22] Risedronate significantly reduces the risk of new vertebral fractures, in women irrespective of the number of prevalent vertebral fractures in just one year
    Eastell, R
    Compston, J
    Roux, C
    Alsayed, N
    Barton, I
    [J]. BONE, 2001, 28 (05) : S225 - S225
  • [23] Correction to: Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study
    E. Kanterewicz
    E. Puigoriol
    J.R. Rodríguez Cros
    P. Peris
    [J]. Osteoporosis International, 2019, 30 : 1901 - 1902
  • [24] Subsequent Vertebral Fracture Risk Is Not A Contraindication to Vertebroplasty or Kyphoplasty
    Han, Shi-Liang
    Wan, Shuang-Lin
    Li, Qing-Tao
    Chen, Ning-Jie
    Yang, Fei
    [J]. PAIN PHYSICIAN, 2013, 16 (02) : E122 - E123
  • [25] The who risk factor index, risk of vertebral fractures and reduction in fracture risk with alendronate: The fracture invervention trial
    Cummings, S. R.
    Palermo, L.
    Ensrud, K. E.
    Schousboe, J. T.
    Johansson, H.
    Kanis, J. A.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S34 - S34
  • [26] Relationship of early changes in bone turnover to the reduction in vertebral fracture risk with risedronate - The HIP study.
    Blumsohn, A
    Barton, IP
    Chines, A
    Eastell, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S89 - S89
  • [27] Risedronate is effective in preventing first vertebral fracture in women
    Fogelman, I
    Ribot, C
    Glowinski, J
    Crozier, R
    [J]. BONE, 2001, 28 (05) : S228 - S228
  • [28] Alendronate and vertebral fracture risk
    Mikhail, N
    Cope, D
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (09) : 1236 - 1236
  • [29] Risk factors for vertebral fracture
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (11): : 582 - 582
  • [30] FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial
    Donaldson, Meghan G.
    Palermo, Lisa
    Schousboe, John T.
    Ensrud, Kristine E.
    Hochberg, Marc C.
    Cummings, Steven R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (11) : 1793 - 1799
12345